258 related articles for article (PubMed ID: 12737068)
1. [Prevention of respiratory syncytial virus infections with palivizumab].
Ellingsen BB; Aase SA; Øymar K
Tidsskr Nor Laegeforen; 2003 Apr; 123(7):941-3. PubMed ID: 12737068
[No Abstract] [Full Text] [Related]
2. Cost effectiveness of palivizumab for RSV prevention in high-risk children in the Netherlands.
Nuijten M; Lebmeier M; Wittenberg W
J Med Econ; 2009; 12(4):291-300. PubMed ID: 19811111
[TBL] [Abstract][Full Text] [Related]
3. [Prophylaxis of respiratory syncytial virus (RSV) in preterm infants with/without bronchopulmonary dysplasia: hyperimmune globulin (RSV-IGIV) and palivizumab (MEDI-493)].
Resch B; Müller W
Klin Padiatr; 1999; 211(6):450-5. PubMed ID: 10592925
[TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus disease: update on treatment and prevention.
Krilov LR
Expert Rev Anti Infect Ther; 2011 Jan; 9(1):27-32. PubMed ID: 21171875
[TBL] [Abstract][Full Text] [Related]
5. [Guidelines for respiratory syncytial virus prophylaxis. An update].
Carbonell-Estrany X; Quero Jiménez J
An Esp Pediatr; 2002 Apr; 56(4):334-6. PubMed ID: 11927077
[TBL] [Abstract][Full Text] [Related]
6. From the American Academy of Pediatrics: Policy statements--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections.
Committee on Infectious Diseases
Pediatrics; 2009 Dec; 124(6):1694-701. PubMed ID: 19736258
[TBL] [Abstract][Full Text] [Related]
7. Nationwide survey of palivizumab for respiratory syncytial virus prevention in Japanese children with congenital heart disease.
Saji T; Nakazawa M; Harada K
Pediatr Infect Dis J; 2008 Dec; 27(12):1108-9. PubMed ID: 18978515
[TBL] [Abstract][Full Text] [Related]
8. [Prophylaxis of respiratory syncytial virus infections with palivizumab].
Danés Carreras I; Arnau De Bolós JM
An Esp Pediatr; 2002 Apr; 56(4):289-91. PubMed ID: 11927094
[No Abstract] [Full Text] [Related]
9. Palivizumab prophylaxis: how to compare pre- and post-prophylaxis eras?
Korppi M
Pediatr Pulmonol; 2007 Jul; 42(7):660; author reply 661. PubMed ID: 17534973
[No Abstract] [Full Text] [Related]
10. Severe respiratory syncytial virus bronchiolitis: epidemiologic variations associated with the initiation of palivizumab in severely premature infants with bronchopulmonary dysplasia.
Grimaldi M; Gouyon B; Michaut F; Huet F; Gouyon JB;
Pediatr Infect Dis J; 2004 Dec; 23(12):1081-5. PubMed ID: 15626942
[TBL] [Abstract][Full Text] [Related]
11. The role of immunoprophylaxis in the reduction of disease attributable to respiratory syncytial virus.
Meissner HC; Bocchini JA; Brady MT; Hall CB; Kimberlin DW; Pickering LK
Pediatrics; 2009 Dec; 124(6):1676-9. PubMed ID: 19948632
[No Abstract] [Full Text] [Related]
12. Palivizumab: a debate about funding.
Fitzgerald DA; Isaacs D; Tobin B
J Paediatr Child Health; 2012 May; 48(5):373-7. PubMed ID: 22296413
[TBL] [Abstract][Full Text] [Related]
13. The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit.
Cox RA; Rao P; Brandon-Cox C
J Hosp Infect; 2001 Jul; 48(3):186-92. PubMed ID: 11439005
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of palivizumab in children with congenital heart disease in Germany.
Nuijten M; Lebmeier M; Wittenberg W
J Med Econ; 2009; 12(4):301-8. PubMed ID: 19811110
[TBL] [Abstract][Full Text] [Related]
15. Immunoprophylaxis of respiratory syncytial virus infection.
Simoes EA
Indian Pediatr; 2000 Mar; 37(3):243-7. PubMed ID: 10750065
[No Abstract] [Full Text] [Related]
16. Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab.
Mahadevia PJ; Malinoski FJ
Arch Pediatr Adolesc Med; 2007 May; 161(5):519-20; author reply 520. PubMed ID: 17485634
[No Abstract] [Full Text] [Related]
17. [Indications and prescription modalities of palivizumab in neonates].
Guillois B
Arch Pediatr; 2007 Sep; 14 Suppl 1():S16-23. PubMed ID: 17939952
[TBL] [Abstract][Full Text] [Related]
18. Controversies in palivizumab use.
Stevens TP; Hall CB
Pediatr Infect Dis J; 2004 Nov; 23(11):1051-2. PubMed ID: 15545862
[No Abstract] [Full Text] [Related]
19. RSV disease--is there a role for prevention?
Lenney W
Respir Med; 2001 Mar; 95(3):170-2. PubMed ID: 11266232
[No Abstract] [Full Text] [Related]
20. Respiratory syncytial virus: different criteria for palivizumab use in different areas?
Mitchell I
South Med J; 2007 Jul; 100(7):661-2. PubMed ID: 17639741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
